Sarepta Therapeutics Inc (NASDAQ:SRPT)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Recs

1
Player Avatar Newt805 (68.74) Submitted: 10/4/2012 4:27:06 PM : Outperform Start Price: $4.14 SRPT Score: +163.03

Is this another NVR?

Member Avatar Mikimikkers (99.76) Submitted: 10/5/2012 5:01:03 PM
Recs: 2

Great call!

Featured Broker Partners


Advertisement